NBP

About NovaBridge Biosciences American Depositary Shares (NBP) Stock

NovaBridge Biosciences American Depositary Shares (NBP) closed the 2026-09-15 session at $1.59, down 1.24% versus the previous close (-0.02). The stock opened at $1.60 and traded between $1.57 and $1.62 during that session. Session trading volume was 280K shares. The volume-weighted average price (VWAP) is $1.59.

NovaBridge Biosciences operates as a biotechnology platform, combining business development and clinical research to identify and advance pharmaceutical assets. Its inventive immuno-oncology pipeline consists of three clinical stage programs, givastomig; uliledlimab; and ragistomig. Its core product, givastomig, is a potential in-class CLDN18.2 bispecific antibody for the treatment of gastric cancer and other CLDN18.2-positive gastrointestinal malignancies.

NovaBridge Biosciences American Depositary Shares has a market capitalization of $186.2 million. NBP is listed on the XNAS exchange. The company employs approximately 30 people. The recorded listing date is 2020-01-17.

On this page you can find market NBP stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.

Explore more: View today's market movers, use the stock screener, or browse all sectors.